Search
NEWS

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study

By A Mystery Man Writer

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traits

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Leonid Padyukov Karolinska Institutet

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Lina Marcela Diaz-Gallo

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Frontiers Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Causal Associations Between Tobacco, Alcohol Use and Risk of Infectious Diseases: A Mendelian Randomization Study

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Randomized, placebo-controlled, crossover trial design. Patients were

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Overview of the Mendelian randomization study design. The Mendelian

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Chronic inflammatory disease epidemiology – Research group Johan Askling